Stable isotope resolved metabolomics analysis of ribonucleotide and RNA metabolism in human lung cancer cells

Metabolomics

Volumn 8, Issue 3, 2012, Pages 517-527

  Fan, Teresa W M ^a,b,c   Tan, Jinlian ^c   McKinney, Martin M ^d   Lane, Andrew N ^a,b,c,d  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b Center for Regulatory Environmental Analytical Metabolomics   (United States)

^c UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^d University of Louisville School of Medicine   (United States)

Author keywords

Nucleotide pools; RNA biosynthesis; Selenium; SIRM

Indexed keywords

GLUCOSE; GLUTAMINE; PURINE DERIVATIVE; PYRIMIDINE; RIBONUCLEOTIDE; RNA; SELENIUM; STABLE ISOTOPE; TRACER;

ARTICLE; CANCER CELL; CELL PROLIFERATION; CITRIC ACID CYCLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; METABOLOMICS; NITROGEN NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE METABOLISM; RNA ANALYSIS; RNA METABOLISM; STABLE ISOTOPE RESOLVED METABOLOMICS;

EID: 84861225466     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-011-0337-9     Document Type: Article

References (39)

1. Bak, L. K., Waagepetersen, H. S., Melo, T. M., Schousboe, A., & Sonnewald, U. (2007). Complex glutamate labeling from [U-C-13]glucose or [U-C-13]lactate in co-cultures of cerebellar neurons and astrocytes. Neurochemical Research, 32, 671-680.
2. Beger, R. D., Hansen, D. K., Schnackenberg, L. K., Cross, B. M., Fatollahi, J. J., Lagunero, F. T., et al. (2009). Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-13C6]-d-glucose tracer in mice. Metabolomics, 5, 336-345.
3. Boren, J., Cascante, M., Marin, S., Comin-Anduix, B., Centelles, J. J., Lim, S., et al. (2001). Gleevec (ST1571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. Journal of Biological Chemistry, 276, 37747-37753.
4. Centelles, J. J., Ramos-Montoya, A., Lim, S., Bassilian, S., Boros, L. G., Marin, S., et al. (2007). Metabolic profile and quantification of deoxyribose synthesis pathways in HepG2 cells. Metabolomics, 3, 105-111.
5. Clark, L. C., Combs, G. F., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., et al. (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin a randomized controlled trial-A randomized controlled trial. Journal of the American Medical Association (JAMA), 276, 1957-1963.
6. Combs, G. F. (2004). Status of selenium in prostate cancer prevention. British Journal of Cancer, 91, 195-199.
7. DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., et al. (2007). Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proceedings of the National Academy of Sciences, 104, 19345-19350.
8. Delgado, T. C., Castro, M. M., Geraldes, C. F., & Jones, J. G. (2004). Quantitation of erythrocyte pentose pathway flux with [2-(13)]glucose and H-1 NMR analysis of the lactate methyl signal. Magnetic Resonance in Medicine, 51, 1283-1286.
9. Fan, T. W.-M. & Lane, A. N. (2011a). Assignment strategies for NMR resonances in metabolomics research. In N. Lutz, J. V. Sweedler & Dr. R. A. Wever (Eds.), Methodologies for metabolomics: Experimental strategies and techniques. New York: Cambridge University Press (in press).
10. Fan, T. W.-M., & Lane, A. N. (2008). Structure-based profiling of metabolites and isotopomers by NMR. Progress in NMR Spectroscopy, 52, 69-117.
11. Fan, T. W. -M., & Lane, A. N. (2011b). NMR-based stable isotope resolved metabolomics in systems biochemistry. Journal of Biomolecular NMR, 49(3-4), 267-280.
12. Fan, T. W. M., Higashi, R. M., Lane, A. N., & Jardetzky, O. (1986). Combined use of proton NMR and gas chromatography-mass spectra for metabolite monitoring and in vivo proton NMR assignments. Biochimica et Biophysica Acta, 882, 154-167.
13. Fan, T. W.-M., Bandura, L., Higashi, R. M., & Lane, A. N. (2005). Metabolomics-edited transcriptomics analysis of Se anticancer action in human lung cancer cells. Metabolomics, 1, 1-15.
14. Fan, T. W. M., Higashi, R. M., & Lane, A. N. (2006). Integrating metabolomics and transcriptomics for probing Se anticancer mechanisms. Drug Metabolism Reviews, 38, 707-732.
15. Fan, T. W.-M., Kucia, M., Jankowski, K., Higashi, R. M., Rataczjak, M. Z., Rataczjak, J., et al. (2008). Proliferating rhabdomyosarcoma cells shows an energy producing anabolic metabolic phenotype compared with primary myocytes. Molecular Cancer, 7, 79.
16. Fan, T. W.-M., Lane, A. N., Higashi, R. M., Farag, M. A., Gao, H., Bousamra, M., et al. (2009). Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM)). Molecular Cancer, 8, 41.
17. Fan, T. W.-M., Yuan, P., Lane, A. N., Higashi, R. M., Wang, Y., Hamidi, A., et al. (2010). Stable isotope resolved metabolomic analysis of lithium effects on glial-neuronal interactions. Metabolomics, 6, 165-179.
18. Ganther, H. E. (1999). Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase. Carcinogenesis (Oxford), 20, 1657-1666.
19. Hiller, K., Metallo, C. M., Kelleher, J. K., & Stephanopoulos, G. (2010). Nontargeted elucidation of metabolic pathways using stable-isotope tracers and mass spectrometry. Analytical Chemistry, 82, 6621-6628.
20. Hu, V. W., Black, G. E., Torres-Duarte, A., & Abramson, F. P. (2002). H-3-thymidine is a defective tool with which to measure rates of DNA synthesis. FASEB Journal, 16(11), 1456-1457.
21. Ip, C., Dong, Y., & Ganther, H. E. (2002). New concepts in selenium chemoprevention. Cancer and Metastasis Reviews, 21, 281-289.
22. Ippel, J., Wijmenga, S., de Jong, B., Heus, H., Hilbers, C., Vroom, E., et al. (1996). Heteronuclear scalar couplings in the bases and sugar rings of nucleic acids: Their determination and application in assignment and conformational analysis. Magnetic Resonance in Chemistry, 34, S156-S176.
23. Lane, A. N., & Fan, T. W.-M. (2007). Quantification and identification of isotopomer distributions of metabolites in crude cell extracts using 1H TOCSY. Metabolomics, 3, 79-86.
24. Lane, A. N., Fan, T. W.-M., & Higashi, R. M. (2008). Isotopomer-based metabolomic analysis by NMR and mass spectrometry. Biophysical Tools for Biologists, 84, 541-588.
25. Lane, A. N., Fan, T. W.-M., Higashi, R. M., Tan, J., Bousamra, M., & Miller, D. M. (2009). Prospects for clinical cancer metabolomics using stable isotope tracers. Journal of Experimental Molecular Pathology, 86, 165-173.
26. Lippman, S. M., Klein, E. A., Goodman, P. J., Lucia, M. S., Thompson, I. M., Ford, L. G., et al. (2009). Effect of selenium and vitamin e on risk of prostate cancer and other cancers: The selenium and vitamin E cancer prevention trial (SELECT). Journal of the American Medical Association (JAMA), 301, 39-51.
27. Lu, X., Bennet, B., Mu, E., Rabinowitz, J., & Kang, Y. (2010). Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model. Journal of Biological Chemistry, 285, 9317-9321.
28. Mancuso, A., Zhu, A. Z., Beardsley, N. J., Glickson, J. D., Wehrli, S., & Pickup, S. (2005). Artificial tumor model suitable for monitoring P-31 and C-13 NMR spectroscopic changes during chemotherapy-induced apoptosis in human glioma cells. Magnetic Resonance in Medicine, 54, 67-78.
29. Mason, G. F., Petersen, K. F., de Graaf, R. A., Shulman, G. I., & Rothman, D. L. (2007). Measurements of the anaplerotic rate in the human cerebral cortex using C-13 magnetic resonance spectroscopy and [1-C-13] and [2-C-13] glucose. Journal of Neurochemistry, 100, 73-86.
30. Mendes, A. C., Caldeira, M. M., Silva, C., Burgess, S. C., Merritt, M. E., Gomes, F., et al. (2006). Hepatic UDP-glucose C-13 isotopomers from [U-C-13]glucose: A simple analysis by C-13 NMR of urinary menthol glucuronide. Magnetic Resonance in Medicine, 56, 1121-1125.
31. Morrish, F., Isern, N., Sadilek, M., Jeffrey, M., & Hockenbery, D. M. (2009). c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene, 28, 2485-2491.
32. Moseley, H. N. B., Lane, A. N., Belshoff, A. C., Higashi, R. M., & Fan, W. W.-M. (2011). Non-steady state modeling of UDP-GlcNAc biosynthesis is enabled by stable isotope resolved metabolomics (SIRM). BMC Biology, 9, 37.
33. Murray, R. K., Bender, D. A., Botham, K. M., Kennelly, P. J., Rodwell, V. W., & Weil, P. A. (2009). Harper's illustrated biochemistry. New York: McGraw-Hill.
34. Nelson, D. L., & Cox, M. M. (2005). Lehninger principles of biochemistry. New York: W. H. Freeman and Company.
35. Telang, S., Lane, A. N., Nelson, K. K., Arumugam, S., & Chesney, J. A. (2007). The oncoprotein H-RasV12 increases mitochondrial metabolism. Molecular Cancer, 6, 77.
36. Vizan, P., Boros, L. G., Figueras, A., Capella, G., Mangues, R., Bassilian, S., et al. (2005). K-ras codon-specific mutations produce distinctive metabolic phenotypes in human fibroblasts. Cancer Research, 65, 5512-5515.
37. Vizan, P., Alcarraz-Vizan, G., Diaz-Moralli, S., Rodriguez-Prados, J. C., Zanuy, M., Centelles, J. J., et al. (2007). Quantification of intracellular phosphorylated carbohydrates in HT29 human colon adenocarcinoma cell line using liquid chromatography-electrospray ionization tandem mass spectrometry. Analytical Chemistry, 79, 5000-5005.
38. Yuneva, M. (2008). Finding an "Achilles' heel" of cancer: the role of glucose and glutamine metabolism in the survival of transformed cells. Cell Cycle, 7, 2083-2089.
39. Zwingmann, C., & Leibfritz, D. (2003). Regulation of glial metabolism studied by C-13-NMR. NMR in Biomedicine, 16, 370-399.